Western Health and Social care trust. Altnagelvin Area Hospital, Glenshane Road, Derry,
Londonderry, Derry, BT47 6SB, United Kingdom
NCT Number: NCT07759830
The goal of this feasibility study/clinical trial is to evaluate the feasibility and acceptability of a CBT group programme (MENOS protocol) for hot flushes and night sweats for National Health Service (in The United Kingdom) healthcare workers experiencing difficult menopause symptoms to inform how to run a larger definitive randomised controlled trial in the future.
The main questions it aims to answer is: [Primary Outcomes] (1) Is the approach of the study feasible (possible to do) and acceptable (Do participants think it is a good approach) in terms of recruitment, completion of measures and the use of a control arm? (2) Is the CBT group (MENOS protocol) intervention feasible and acceptable for the participants based on retention, satisfaction, acceptability and feasibility ratings of the intervention and participant feedback? [Secondary Outcomes] (3) Are the menopause and work-related outcome questionnaires able to capturing change to inform the selection of measures for a future definitive Randomised Controlled Trial? (4) Did the participants find completing self-reported memory measures acceptable? Participants will be allocated to an intervention and control arm but the arms will not be compared as this is a feasibility study not designed to test the effectiveness of the intervention. Rather it is to evaluate the acceptability of a control arm and the approach of the study for a future larger trial.
Intervention Participants will be: asked to attend a 6 x 2hours weekly CBT group therapy sessions for menopause related Hot flushes and Night Sweats. Intervention Participants will be invited to take part in a focus group post intervention.
All participants (Control and Intervention arm) will be asked to complete online survey at pre-intervention, post-intervention and at 3-months after the end of the intervention.
At the end of the study, the control arm will be offered a guided self-help CBT book of the programme.
Looking for future studies?
Notify Me40 year–60 year
Female
Interventional
Not applicable
Londonderry, Derry, BT47 6SB, United Kingdom
Challenging menopause symptoms can affect healthcare workers' well-being and work life, potentially contributing to career changes and thus impacting workforce retention and health service delivery. Increasing numbers of UK National Health Service (NHS) workers are working through menopause transition and reporting problematic menopausal symptoms in the workplace. Although psychosocial interventions have been developed for menopause, the evaluation of their effectiveness within the healthcare workforce remains scarce . This study assesses the feasibility and acceptability of a Cognitive Behavioural Therapy (CBT) group intervention for UK NHS workers experiencing problematic hot flushes/night sweats (HF/NS).
A mixed-methods design employing a randomised two-arm parallel design with intervention and control conditions was used to assess feasibility and acceptability. Measures of menopause symptoms, beliefs and behaviour, midlife female health, memory and of the menopause-related impact on work were collected through online surveys from both study arms at baseline (6 days before the start of the intervention), post-intervention (to be sent within 1 week of the last intervention session) and three months post-intervention. Focus groups were conducted around 4 months after completion of the intervention with participants in the intervention group to gather their perspectives on the acceptability of the study and intervention. The extension of the CONSORT 2010 checklist for feasibility trials was used for reporting this study.
Participants and Recruitment Procedure. Participants were recruited from NHS workers in a single Health Service Trust in Northern Ireland (UK) between March and June 2025. The project was advertised through a direct email to a Trust-wide staff mailing list, Trust social media, the Trust-based menopause café and posters in the workplace. Recruitment material directed staff to register interest with a designated member of the research team based in the Trust via telephone or email. Trust Occupational Health also provided staff who were referred to their service with menopausal complaints with recruitment information on the study. An eligibility screening tool was developed and completed with all participants by phone or via email. Those deemed eligible were sent a participant information sheet and an informed consent form. Once, the participants consented by completing a consent form, they were randomly allocated to either the intervention or control arm until a sufficient sample size was generated. Further Information on inclusion and exclusion criteria is included later in the application.
Measure Collection and Anonymity. Once consent was given and participants were allocated to either the intervention or control arm, they were sent an email by a designated member of the research team with a link to online questionnaires. Participants were issued with a computer-generated code to complete the first survey. This code was known only to them. They were asked to make note of this code and re-use it for completing further questionnaires at Time Point 2 (Post-Intervention) & Time Point 3 (3-month-follow up). Therefore, there was no link between the participants' identifiable information and the coded data that they provided throughout the study.
Intervention The intervention arm received the CBT group programme for menopausal symptoms - Hot Flushes/Night Sweats (using the MENOS protocol) for 6 weeks in weekly two-hour sessions. The intervention includes psychoeducation about menopause, the hot flushes cognitive behavioural model, plus the identification of triggers, stress management, sleep hygiene, cognitive techniques and paced breathing techniques. The CBT intervention was held during working hours in a healthcare setting and was delivered by two facilitators, a trainee clinical psychologist/CBT therapist and a senior nurse. The control arm continued to receive usual care. At the end of the study, participants in the control arm were offered a self-help book of the CBT programme for hot flushes and night sweats.
Primary Outcome Measures
Completion rates of self-report measures of menopause symptoms, work and memory measures at three time points were a primary outcome to examine the acceptability and feasibility of the measures and the collection method for a future definitive Randomised Controlled Trial.
At the post-intervention survey, participants were asked whether they found the randomisation process acceptable, while the control arm participants were also asked if they found their allocation to the control group acceptable.
Secondary Outcomes (3) Responsiveness of Measures. Quantitative self-report measures were collected to provide preliminary data on their potential sensitivity to capture change within a healthcare population to inform outcome measures in a future RCT. Further information on the Secondary outcome measures is included later in the application form.
(4) Acceptability of completing self-reported memory measures. (see Brief description). At the post-intervention survey, all participants were asked if they found completing the memory measures acceptable. Completion rates were also used for this assessment.
Sample Size The target sample size was 40 participants, with 20 participants to be allocated to each study arm. As this was a feasibility study conducted in line with the CONSORT 2010 extension guidelines, a formal sample size calculation was not be computed.
Randomisation and Allocation Method Participants were randomly allocated to the intervention and control arm using a digitally generated randomisation prior to study commencement. Allocation was completed by a researcher blinded to participant identities while participant names were be only known to the screener.
Data Analysis Participant characteristics were described using means and standard deviation for continuous variables and frequencies and percentages for categorical variables. Recruitment, eligibility, retention and measure completion were be reported as percentages. Recruitment reach was estimated as the proportion of potentially eligible staff who expressed interest. Intervention attendance was described using the mean number of sessions attended and the overall attendance percentage. AIM, FIM, IAM and CSQ outcomes were summarised using mean scores and standard deviations, with recommended guidelines used to interpret outcome levels. Qualitative data was examined using reflexive thematic analysis.
For the secondary objectives, analyses were conducted to examine the sensitivity of each outcome measure to detect change over time and determine their suitability for a future RCT. As this was an exploratory feasibility study, the analysis focused on the magnitude and precision of the change estimate rather than statistical significance. Effect sizes were used to conduct an a priori analysis to estimate the sample size required to ensure 80% power, with an alpha level of .05 in a future RCT. The effect size estimate was calculated as the difference in mean pre-post change between the intervention and control arms, divided by the pooled baseline standard deviation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
CBT group programme for menopausal symptoms of Hot Flushes/Night Sweats (using the MENOS protocol) for 6 weeks in weekly two-hour sessions. The intervention includes psychoeducation about hot flushes in menopause and the Hot Flush/Night Sweats cognitive behavioural model, plus the identification of triggers, stress management, sleep hygiene and paced breathing techniques
No Intervention. Treatment as usual
Time frame: 10 weeks. Between March 22nd and June 1st 2025
This includes the number of participants who expressed interest. Number of participants screened for eligibility. Number of eligible participants. Number of participants who consented and were enrolled in study.
Time frame: 9 weeks - includes the 6 week intervention and allocation run in time.
Number of participants allocated to intervention who started the intervention, Number who dropped out of intervention.
Time frame: Collected over the 6 weeks of the intervention.
Collected by intervention facilitator. Overall mean attendance for all participants will be calculated and a percentage will also be calculated
Time frame: 7 weeks after start of intervention.
Completed by Intervention arm in an online survey. These measures are administered to determine the extent to which participants believe an intervention or an implementation strategy is acceptable. These are four-item measures of implementation outcomes that are considered indicators of implementation success. Scored by summing the 4 items within each scale, where 1 = "completely disagree" and 5 = "completely agree". Each measure produces a score from 4 to 20, with higher scores indicating higher acceptability, appropriateness, or feasibility. Scale Range: Each of the 4 items in each questionnaire (AIM, IAM, FIM) is rated on a 5-point Likert scale. Mean and standard deviation scores will calculated to assess the acceptability, feasibility and appropriateness of the CBT intervention for the intervention participants. Maximum raw score 20. Scores above 15 indicate high levels of the measures.
Time frame: 7 weeks after start of intervention.
Completed by participants from the intervention arm in online survey. An unidimensional measure of global satisfaction with programmes with high internal reliability and Cronbach's alpha of 0.92- 0.93. Maximum raw score 32. Will be rated using scoring guidelines.
Time frame: Baseline, 7 weeks and 18 weeks.
Overall completion rates by both arms of online survey measures at baseline, post-intervention and 3-months follow up post-intervention reported as percentage.
Completion rates by the intervention arm of the online survey measures at baseline, post-intervention and 3-months follow up post-intervention reported as percentage.
Completion rates by the control arm of the online survey measures at baseline, post-intervention and 3-months follow up post-intervention reported as percentage.
Used to calculate attrition rates in both groups.
Time frame: 7 weeks after start of intervention.
Q 1.All participants were asked if they found the random allocation to the intervention and control arms acceptable.
Q2. Participants in the control arm were asked if they found allocation to the control group was acceptable.
Scored on scale with 4 items (score 1-4) - No definitely not; No not really; Yes, generally, Yes definitely. Mean score calculated.
Time frame: Baseline, 7 weeks and 18 weeks.
This yields a HF/NS frequency score for the previous week, a HF/NS Severity score (Mild, Moderate or Severe) and a HF/NS problem rating (Scale 0-10). Cronbach's alpha (α) for the HF/NS problem rating measure was reported as 0.83. This measure will be used to evaluate the responsiveness of the measure to change and to calculate preliminary effect size for sample estimate for definitive future RCT.
Time frame: Baseline, 7 weeks and 18 weeks.
The Short Form HFBBS is a 16-item scale that includes items from the Hot Flush Beliefs Scale [50] and the Hot Flush Behaviour Scale [51]. Consists of 5 subscales. Items are scored 0-5 with items added and then divided by number of subscale score. Cronbach's alpha for the subscales was reported as: social context (α=.90), Beliefs about HF/NS (α=.73), Beliefs about coping and control (α=.78), Positive coping behaviour (α=.60), Avoidance (α=.76). This measure will be used to evaluate the responsiveness of the measure to change and to calculate preliminary effect size for sample estimate for definitive future RCT.
Time frame: Baseline, 7 weeks and 18 weeks.
A 36-item scale designed for midlife women that measures nine factors of health functioning, including somatic, menstrual, and vasomotor symptoms, as well as problems in mood, anxiety, memory, sleep, and sexual behaviour. (Cronbach's alpha (α) = 0.83). Uses Likert scale with 4 points. Scoring guidelines recommend - Subscale scores are derived by summing the symptom scores into binary scores, recoded as present or absent (Yes definitely and Yes sometimes are scored 1 and No not at all and No not much are scored 0). This long version of the measure will be used to evaluate the responsiveness of the measure to change and to calculate preliminary effect size for sample estimate for definitive future RCT.
Time frame: Baseline, 7 weeks and 18 weeks.
A five-item scale measures functional impairment at home, work and in social situations attributed to Menopause. 5 questions using Likert scale 0 to 8 (From not at all to very severely). Score range 0-40. Cronbach's alpha measure of internal scale consistency ranged from 0.70 to 0.94. This measure will be used to evaluate the responsiveness of the measure to change and to calculate preliminary effect size for sample estimate for definitive future RCT. WSAS scoring guidelines used to assess scores.
Time frame: Baseline, 7 weeks and 18 weeks.
Subjective self-reported memory scale. The MFQ uses 64 items rated on 7-point scales from which four factors are calculated: Frequency of forgetting; Seriousness of forgetting; Retrospective Functioning; and Mnemonics Usage. Internal consistency of the factor scores are reported as high with alpha values ranging from .94 to .83. This measure will be used to evaluate the responsiveness of the measure to change and to calculate preliminary effect size for sample estimate for definitive future RCT.
Queen's University, Belfast
Other
Evaluating the Feasibility of a CBT Group Therapy Programme (MENOS Protocol ) for NHS Staff With Problematic Menopause Symptoms.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07408115
Hot Flash, Hot Flashes
Harrison, New York, United States
View Trial DetailsNCT05042362
Hot Flashes, Pathological Conditions, Signs and Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT05099159
Hot Flashes, Pathological Conditions, Signs and Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT05030584
Hot Flashes, Pathological Conditions, Signs and Symptoms
Mobile, Alabama, United States
View Trial Details